Abivax SA (AAVXF)
15.15
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Abivax Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2019 | 1.116 |
June 30, 2019 | 1.042 |
December 31, 2018 | 0.3145 |
June 30, 2018 | 0.00 |
December 31, 2017 | 0.00 |
June 30, 2017 | 0.0065 |
Date | Value |
---|---|
December 31, 2016 | 0.0056 |
June 30, 2016 | 0.0007 |
December 31, 2015 | 0.0004 |
June 30, 2015 | 0.0071 |
December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
1.042
Minimum
Jun 2019
1.116
Maximum
Dec 2019
1.079
Average
1.079
Median
Debt to Equity Ratio Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 0.3968 |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 0.9462 |
Innate Pharma SA | 0.7525 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 361.53M |
Total Liabilities (Quarterly) | 144.86M |
Shareholders Equity (Quarterly) | 216.67M |